CalmiGo Overview
- Year Founded
-
2018

- Status
-
Private
- Employees
-
29

- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$11M
- Investors
-
14
CalmiGo General Information
Description
Developer of a drug-free medical device designed to provide immediate relief from emotional and mental distress. The company's device uses advanced patented technology that provides immediate, drug-free relief for moments of distress, anxiousness, and stress by regulating breathing patterns and stimulating the senses, enabling users to get a portable device that can treat anxiety issues regardless of age, location, or technical abilities.
Contact Information
Website
www.calmigo.comCorporate Office
- 430 West 116th Street
- Apartmentt 1ER
- New York, NY 10027
- United States
Corporate Office
- 430 West 116th Street
- Apartmentt 1ER
- New York, NY 10027
- United States
CalmiGo Timeline
CalmiGo Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Seed Round | 29-Jan-2024 | $11M | Completed | Generating Revenue | ||
5. Accelerator/Incubator | Completed | Generating Revenue | ||||
4. Accelerator/Incubator | 25-Oct-2021 | Completed | Generating Revenue | |||
3. Seed Round | 01-Mar-2021 | Completed | Generating Revenue | |||
2. Seed Round | 01-Jan-2020 | $575K | $575K | Completed | Startup | |
1. Accelerator/Incubator | 01-Mar-2018 | Completed | Startup |
CalmiGo Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed-5 | ||||||||
Seed-4 | ||||||||
Seed-3 | ||||||||
Seed-2 | 5,450,237 | $0.000100 | $0.11 | $0.11 | 1x | $0.11 | 2.71% | |
Seed-1 | 95,856,387 | $0.000100 | $0.14 | $0.14 | 1x | $0.14 | 47.62% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CalmiGo Patents
CalmiGo Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-D996619-S1 | Device that measures exhalation duration | Active | 04-Jan-2022 | ||
CA-3236974-A1 | Inhalation and exhalation devices | Pending | 08-Nov-2021 | ||
EP-4429740-A1 | Inhalation and exhalation devices | Pending | 08-Nov-2021 | ||
US-20240424231-A1 | Inhalation and exhalation devices | Pending | 08-Nov-2021 | A61M15/0021 |
CalmiGo Signals
CalmiGo Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
2B.VC | Venture Capital | Minority | ||
Five Eyes Venture | Venture Capital | Minority | ||
Grove Ventures | Venture Capital | Minority | ||
Jibe Ventures | Venture Capital | Minority | ||
Nina Capital | Venture Capital | Minority |
CalmiGo FAQs
-
When was CalmiGo founded?
CalmiGo was founded in 2018.
-
Where is CalmiGo headquartered?
CalmiGo is headquartered in New York, NY.
-
What is the size of CalmiGo?
CalmiGo has 29 total employees.
-
What industry is CalmiGo in?
CalmiGo’s primary industry is Therapeutic Devices.
-
Is CalmiGo a private or public company?
CalmiGo is a Private company.
-
What is the current valuation of CalmiGo?
The current valuation of CalmiGo is
. -
What is CalmiGo’s current revenue?
The current revenue for CalmiGo is
. -
How much funding has CalmiGo raised over time?
CalmiGo has raised $24.6M.
-
Who are CalmiGo’s investors?
2B.VC, Five Eyes Venture, Grove Ventures, Jibe Ventures, and Nina Capital are 5 of 14 investors who have invested in CalmiGo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »